33 results match your criteria: "The Baron Edmond de Rothschild Chemical Dependency Institute[Affiliation]"

Aims: The Ethnic Minority Meta-Analysis (EMMA) aims to assess racial/ethnic disparities in HIV infection among people who inject drugs (PWID) across various countries. This is the first report of the data.

Methods: Standard systematic review/meta-analysis methods were utilized, including searching for, screening and coding published and unpublished reports and meta-analytical statistics.

View Article and Find Full Text PDF

Background: Injecting drug use continues to be a primary driver of HIV epidemics in many parts of the world. Many people who inject drugs (PWID) are sexually active, so it is possible that high-seroprevalence HIV epidemics among PWID may initiate self-sustaining heterosexual transmission epidemics.

Methods: Fourteen countries that had experienced high seroprevalence (<20%) HIV epidemics among PWID and had reliable data for injection drug use (IDU) and heterosexual cases of HIV or AIDS were identified.

View Article and Find Full Text PDF

Objective: There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed.

Design: International systematic review and meta-analysis of studies across 14 countries.

View Article and Find Full Text PDF

Beth Israel Medical Center (BIMC), in collaboration with the Centers for Disease Control (CDC) and the New York State Department of Health (NYSDOH), used respondent-driven sampling (RDS) in a study of HIV seroprevalence among drug users in New York City in 2004. We report here on operational issues with RDS including recruitment, coupon distribution, storefront operations, police and community relations, and the overall lessons we learned. Project staff recruited eight seeds from a syringe exchange in Lower Manhattan to serve as the initial study participants.

View Article and Find Full Text PDF

Expansion of opiate agonist treatment: an historical perspective.

Harm Reduct J

July 2006

The Baron Edmond de Rothschild Chemical Dependency Institute of Beth Israel Medical Center, Albert Einstein College of Medicine of Yeshiva University, 555 West 57th Street, 18th Floor, New York, NY 10019, USA.

Untreated opiate addiction remains a major health care crisis in New York and in most other urban centers in America. Optimism for closing the gap between need and demand for treatment and its availability has greeted the recent approval of a new opiate medication for addiction, buprenorphine--which unlike methadone may be prescribed by independent, office-based practitioners. The likelihood of buprenorphine fulfilling its potential is assessed in the light of the massive expansion of methadone treatment more than 30 years earlier.

View Article and Find Full Text PDF

Comment on Soar, et al.'s case study of problems and use of Ecstasy.

Psychol Rep

April 2005

The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, USA.

This case report provides no basis for drawing any conclusions regarding possible adverse effects of use of Ecstasy.

View Article and Find Full Text PDF

Long-term effects of syringe exchange on risk behavior and HIV prevention.

AIDS Educ Prev

June 2004

The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA.

The purpose of this study was to assess stability of population-level injection risk behavior over time among participants in a syringe exchange program and compare factors affecting syringe sharing at two points in time. Participants of the Tacoma Syringe Exchange Program were interviewed in 1997 and 2001 using audio computer assisted self-interviewing technology. In each wave of data collection, a random cross section of participants was recruited and interviewed, with no attempt made to follow respondents over time.

View Article and Find Full Text PDF

Methadone treatment: common questions, a common answer.

Ann Med Interne (Paris)

November 2001

The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, 10003 New York City, NY, USA.

View Article and Find Full Text PDF